Home › Pancreatic Cancer › Pennsylvania › Philadelphia
Pancreatic Cancer clinical trials in Philadelphia, PA
26 studies for Pancreatic Cancer are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 3
- Thomas Jefferson University, Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Philadelphia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 3
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
- Investigative Site US008, Philadelphia
- Investigative Site US043, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- Hospital of the University of Pennsylvania, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Recruiting
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 2
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office, Philadelphia
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- and 5 more
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi away
- and 1 more
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Investigative Site #109, Philadelphia
Pancreatic Cancer Early Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- Sidney Kimmel Cancer Center, Philadelphia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecruitingPhase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi away
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi away
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Collection of Circulating Biomarkers in Pancreatic Cancer
RecruitingObservational study
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RecruitingPhase 2
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University-Telemedicine, Philadelphia
- Ohio State University-Telemedicine, Wilmington · 25 mi away
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
RecruitingObservational study
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
FTT PET/CT in Pancreatic Neuroendocrine Tumors
RecruitingPhase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecruitingObservational study
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- University of Pennsylvania, Philadelphia
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Tampa, FL26 studies
- Durham, NC24 studies
- San Diego, CA24 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.